Doctors urged to discuss use of breast cancer prevention drugs

07/9/2013 | HealthDay News

The American Society of Clinical Oncology issued new practice guidelines urging physicians to discuss the use of so-called chemopreventive drugs with their female patients at high risk of breast cancer. Doctors should explain the risks and benefits of tamoxifen for high-risk premenopausal women, and those of tamoxifen, raloxifene and exemestane for high-risk postmenopausal women. The recommendations were published in the Journal of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care